BORRBangladesh Open Research Repository
SearchSubmitAboutContact
BORRResearch for a Better Bangladesh.
AboutSubmit PaperContactTermsPolicyGitHub

© 2026 Bangladesh Open Research Repository.

Filters

Sort By

Sort by dateSort by citations
Year Range
to
Clear all filters

All Papers

16+ results
Field: Oncology

Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study

Verified

Silvia de Sanjosé, Wim Quint, Laia Alemany, D.T. Geraets et al.

Journal: The Lancet OncologyYear: 2010
Citations: 2725

Background Knowledge about the distribution of human papillomavirus (HPV) genotypes in invasive cervical cancer is crucial to guide the introduction of prophylactic vaccines. We aimed to provide novel and comprehensive data about the worldwide genotype distribution in patients with invasive cervical...

Health SciencesMedicineEpidemiology
Read Source

Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017

Verified

Christina Fitzmaurice, Degu Abate, Naghmeh Abbasi, Hedayat Abbastabar et al.

Journal: JAMA OncologyYear: 2019Citations: 2660

<h3>Importance</h3> Cancer and other noncommunicable diseases (NCDs) are now widely recognized as a threat to global development. The latest United Nations high-level meeting on NCDs reaffirmed this observation and also highlighted the slow progress in meeting the 2011 Political Declaration on the P...

Health SciencesMedicineOncologyOpen Access
Read Source

Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism

Verified

Gary E. Raskob, Nick van Es, Peter Verhamme, Marc Carrier et al.

Journal: New England Journal of MedicineYear: 2017Citations: 1599

BACKGROUND: Low-molecular-weight heparin is the standard treatment for cancer-associated venous thromboembolism. The role of treatment with direct oral anticoagulant agents is unclear. METHODS: In this open-label, noninferiority trial, we randomly assigned patients with cancer who had acute symptoma...

Health SciencesMedicineInternal MedicineOpen Access
Read Source

Short-Course Radiation plus Temozolomide in Elderly Patients with Glioblastoma

Verified

James Perry, Normand Laperrière, Christopher J. O’Callaghan, Alba A. Brandes et al.

Journal: New England Journal of MedicineYear: 2017Citations: 1171

BACKGROUND: Glioblastoma is associated with a poor prognosis in the elderly. Survival has been shown to increase among patients 70 years of age or younger when temozolomide chemotherapy is added to standard radiotherapy (60 Gy over a period of 6 weeks). In elderly patients, more convenient shorter c...

Health SciencesMedicineGeneticsOpen Access
Read Source

The global burden of women’s cancers: a grand challenge in global health

Verified

Ophira Ginsburg, Freddie Bray, Michel P. Coleman, Verna Vanderpuye et al.

Journal: The LancetYear: 2016Citations: 1133

Each year, more than 2 million women are diagnosed with breast or cervical cancer, yet where a woman lives largely determines whether she will develop one of these cancers, have access to timely and effective diagnostic and treatment services, and ultimately survive. Premature death and disability f...

Health SciencesMedicineOncologyOpen Access
Read Source

Colorectal Cancer: A Review of Carcinogenesis, Global Epidemiology, Current Challenges, Risk Factors, Preventive and Treatment Strategies

Verified

Md. Sanower Hossain, Hidayah Karuniawati, Ammar Abdulrahman Jairoun, Zannat Urbi et al.

Journal: CancersYear: 2022Citations: 849

Colorectal cancer (CRC) is the second most deadly cancer. Global incidence and mortality are likely to be increased in the coming decades. Although the deaths associated with CRC are very high in high-income countries, the incidence and fatalities related to CRC are growing in developing countries t...

Health SciencesMedicineOncologyOpen Access
Read Source

The global, regional, and national burden of pancreatic cancer and its attributable risk factors in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017

Verified

Akram Pourshams, Sadaf G Sepanlou, Kevin S Ikuta, Catherine Bisignano et al.

Journal: ˜The œLancet. Gastroenterology & hepatologyYear: 2019Citations: 668

BACKGROUND: Worldwide, both the incidence and death rates of pancreatic cancer are increasing. Evaluation of pancreatic cancer burden and its global, regional, and national patterns is crucial to policy making and better resource allocation for controlling pancreatic cancer risk factors, developing ...

Health SciencesMedicineOncologyOpen Access
Read Source

P-glycoprotein Inhibition for Optimal Drug Delivery

Verified

Md. Lutful Amin

Journal: Drug Target InsightsYear: 2013Citations: 620

P-glycoprotein (P-gp), an efflux membrane transporter, is widely distributed throughout the body and is responsible for limiting cellular uptake and the distribution of xenobiotics and toxic substances. Hundreds of structurally diverse therapeutic agents are substrates to it and it impedes the absor...

Health SciencesMedicineOncologyOpen Access
Read Source

Transcriptional programs of neoantigen-specific TIL in anti-PD-1-treated lung cancers

Verified

Justina X. Caushi, Jiajia Zhang, Zhicheng Ji, Ajay Vaghasia et al.

Journal: NatureYear: 2021Citations: 543

Abstract PD-1 blockade unleashes CD8 T cells 1 , including those specific for mutation-associated neoantigens (MANA), but factors in the tumour microenvironment can inhibit these T cell responses. Single-cell transcriptomics have revealed global T cell dysfunction programs in tumour-infiltrating lym...

Health SciencesMedicineOncologyOpen Access
Read Source

Multidrug Resistance in Cancer: Understanding Molecular Mechanisms, Immunoprevention and Therapeutic Approaches

Verified

Talha Bin Emran, Asif Shahriar, Aar Rafi Mahmud, Tanjilur Rahman et al.

Journal: Frontiers in OncologyYear: 2022Citations: 541

Cancer is one of the leading causes of death worldwide. Several treatments are available for cancer treatment, but many treatment methods are ineffective against multidrug-resistant cancer. Multidrug resistance (MDR) represents a major obstacle to effective therapeutic interventions against cancer. ...

Health SciencesMedicineOncologyOpen Access
Read Source

Intrahepatic Cholestasis of Pregnancy

Verified

Catherine Williamson, Victoria Geenes

Journal: Obstetrics and GynecologyYear: 2014Citations: 468

In Brief Intrahepatic cholestasis of pregnancy is the most common pregnancy-specific liver disease that typically presents in the third trimester. The clinical features are maternal pruritus in the absence of a rash and deranged liver function tests, including raised serum bile acids. Intrahepatic c...

Health SciencesMedicineOncology
Read Source

Activation of STING-Dependent Innate Immune Signaling By S-Phase-Specific DNA Damage in Breast Cancer

Verified

Eileen E. Parkes, Steven M. Walker, Laura E. Taggart, Nuala McCabe et al.

Journal: JNCI Journal of the National Cancer InstituteYear: 2016Citations: 459

Background: Previously we identified a DNA damage response-deficient (DDRD) molecular subtype within breast cancer. A 44-gene assay identifying this subtype was validated as predicting benefit from DNA-damaging chemotherapy. This subtype was defined by interferon signaling. In this study, we address...

Health SciencesMedicineOncologyOpen Access
Read Source

Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors: Guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology

Verified

Neal I. Lindeman, Philip T. Cagle, Mary Beth Beasley, Dhananjay Chitale et al.

Journal: Archives of Pathology & Laboratory MedicineYear: 2013Citations: 428

OBJECTIVE: To establish evidence-based recommendations for the molecular analysis of lung cancers that are required to guide EGFR- and ALK-directed therapies, addressing which patients and samples should be tested, and when and how testing should be performed. PARTICIPANTS: Three cochairs without co...

Health SciencesMedicinePulmonary and Respiratory MedicineOpen Access
Read Source

An enhanced technique of skin cancer classification using deep convolutional neural network with transfer learning models

Verified

Md Shahin Ali, Md Sipon Miah, Jahurul Haque, Mahbubur Rahman et al.

Journal: Machine Learning with ApplicationsYear: 2021Citations: 401

Skin cancer is one of the top three perilous types of cancer caused by damaged DNA that can cause death. This damaged DNA begins cells to grow uncontrollably and nowadays it is getting increased speedily. There exist some researches for the computerized analysis of malignancy in skin lesion images. ...

Health SciencesMedicineOncologyOpen Access
Read Source

Real-Time Polyp Detection, Localization and Segmentation in Colonoscopy Using Deep Learning

Verified

Debesh Jha, Sharib Ali, Nikhil Kumar Tomar, Håvard D. Johansen et al.

Journal: IEEE AccessYear: 2021Citations: 388

Computer-aided detection, localisation, and segmentation methods can help improve colonoscopy procedures. Even though many methods have been built to tackle automatic detection and segmentation of polyps, benchmarking of state-of-the-art methods still remains an open problem. This is due to the incr...

Health SciencesMedicineOncologyOpen Access
Read Source
PreviousPage 1 of 2+Next